Whole article was originally published here.
Missouri lawmakers passed a bill last week that would prevent state licensing boards from disciplining physicians who prescribe the wonder drugs Ivermectin and hydroxychloroquine.
The bill also prohibits pharmacists from questioning the prescription and its effectiveness. Missouri legislature passed HB 2149, which modifies provisions relating to professional licensing with a vote of 139-4 last week, according to The Kansas City Star. The legislation now heads to the governor’s desk for his consideration.
“The board shall not deny, revoke, or suspend, or otherwise take any disciplinary action against, a certificate of registration or authority, permit, or license required by this chapter for any person due to the lawful dispensing, distributing, or selling of ivermectin tablets or hydroxychloroquine sulfate tablets for human use in accordance with prescriber directions. A pharmacist shall not contact the prescribing physician or the patient to dispute the efficacy of ivermectin tablets or hydroxychloroquine sulfate tablets for human use unless the physician or patient inquires of the pharmacist about the efficacy of ivermectin tablets or hydroxychloroquine sulfate tablets.”
Japan’s Kowa company also found Ivermectin has an “antiviral effect” against Omicron and other COVID-19 variants as Phase III clinical trials continue, Reuters reported.
Even a clinical trial conducted by MedinCells and funded by the Bill and Melinda Gates Foundation confirmed the safety of ivermectin taken daily in oral form.
According to the press release, there were no side effects observed with the three doses of ivermectin tested up to 100 μg/kg in continuous administration over 1 month in healthy volunteers.